Millennium Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-510,536
Closed -$14.3M 7874
2022
Q1
$14.3M Sell
510,536
-496,083
-49% -$13.6M 0.01% 1747
2021
Q4
$27.5M Sell
1,006,619
-569,067
-36% -$15.4M 0.01% 1167
2021
Q3
$42.9M Buy
1,575,686
+1,442,615
+1,084% +$35.7M 0.03% 725
2021
Q2
$2.27M Buy
+133,071
New +$2.49M ﹤0.01% 3807
2021
Q1
Sell
-11,842
Closed -$271K 6715
2020
Q4
$271K Buy
+11,842
New +$225K ﹤0.01% 4618
2019
Q4
Sell
-23,531
Closed -$477K 4784
2019
Q3
$400K Sell
23,531
-888,575
-97% -$16.2M ﹤0.01% 3399
2019
Q2
$20.8M Sell
912,106
-427,067
-32% -$11.5M 0.03% 759
2019
Q1
$43.1M Buy
1,339,173
+91,390
+7% +$2.83M 0.06% 394
2018
Q4
$35.2M Buy
1,247,783
+225,853
+22% +$6.61M 0.05% 468
2018
Q3
$29.4M Buy
1,021,930
+924,360
+947% +$27.8M 0.04% 646
2018
Q2
$3.65M Sell
97,570
-237,440
-71% -$9.32M ﹤0.01% 2010
2018
Q1
$13.2M Buy
335,010
+37,153
+12% +$1.36M 0.02% 1154
2017
Q4
$9.65M Sell
297,857
-89,456
-23% -$2.68M 0.01% 1349
2017
Q3
$12.1M Sell
387,313
-519,134
-57% -$15.4M 0.02% 1125
2017
Q2
$25.3M Buy
906,447
+775
+0.1% +$17.5K 0.05% 568
2017
Q1
$15.5M Sell
905,672
-253,860
-22% -$3.56M 0.03% 789
2016
Q4
$14M Buy
1,159,532
+387,667
+50% +$5.02M 0.03% 746
2016
Q3
$12.2M Sell
771,865
-1,774
-0.2% -$26.7K 0.02% 817
2016
Q2
$10M Buy
+773,639
New +$12.1M 0.02% 847
2016
Q1
Sell
-10,286
Closed -$231K 3790
2015
Q4
$231K Sell
10,286
-29,714
-74% -$587K ﹤0.01% 3035
2015
Q3
$936K Sell
40,000
-281,259
-88% -$7.76M ﹤0.01% 2317
2015
Q2
$9.2M Sell
321,259
-98,768
-24% -$2.59M 0.02% 1030
2015
Q1
$10.8M Buy
420,027
+117,949
+39% +$2.7M 0.02% 975
2014
Q4
$5.6M Sell
302,078
-43,963
-13% -$791K 0.01% 1316
2014
Q3
$5.36M Buy
+346,041
New +$5.21M 0.01% 1252

Millennium Management's XENT Position: Q2 2022 in Review

Millennium Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 510,536 shares — an estimated $14.3M sold.

Millennium Management first reported a position in XENT in Q3 2014 and held it in 25 quarters. The position peaked at $43.1M in Q1 2019. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Millennium Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Millennium Management sold 510,536 Intersect ENT, Inc shares in Q2 2022, an estimated $14.3M.
  • Millennium Management first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 25 quarters.
  • Millennium Management's Intersect ENT, Inc position peaked at $43.1M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.